Cargando…
Plasma microRNA biomarkers for detection of mild cognitive impairment: Biomarker Validation Study
A minimally invasive test for early detection and monitoring of Alzheimer's and other neurodegenerative diseases is a highly unmet need for drug development and planning of patient care. Mild Cognitive Impairment (MCI) is a syndrome characteristic of early stages of many neurodegenerative disea...
Autores principales: | Sheinerman, Kira S., Tsivinsky, Vladimir G., Abdullah, Laila, Crawford, Fiona, Umansky, Samuil R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883708/ https://www.ncbi.nlm.nih.gov/pubmed/24368295 |
Ejemplares similares
-
Plasma microRNA biomarkers for detection of mild cognitive impairment
por: Sheinerman, Kira S., et al.
Publicado: (2012) -
Brain-enriched microRNAs circulating in plasma as novel biomarkers for Rett syndrome
por: Sheinerman, Kira, et al.
Publicado: (2019) -
Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: feasibility study
por: Sheinerman, Kira S, et al.
Publicado: (2013) -
Age- and sex-dependent changes in levels of circulating brain-enriched microRNAs during normal aging
por: Sheinerman, Kira, et al.
Publicado: (2018) -
Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies
por: Sheinerman, Kira S., et al.
Publicado: (2013)